Transgene SA (EPA:TNG)
0.7140
+0.0030 (0.42%)
Aug 3, 2026, 12:42 PM CET
Transgene Revenue
In the year 2025, Transgene had annual revenue of 7.21M EUR with 13.49% growth. Transgene had revenue of 139.00K in the half year ending December 31, 2025.
Revenue
7.21M
Revenue Growth
+13.49%
P/S Ratio
27.01
Revenue / Employee
49.72K
Employees
145
Market Cap
194.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.21M | 857.00K | 13.49% |
| Dec 31, 2024 | 6.35M | -1.55M | -19.58% |
| Dec 31, 2023 | 7.90M | -2.44M | -23.63% |
| Dec 31, 2022 | 10.34M | -7.07M | -40.60% |
| Dec 31, 2021 | 17.41M | 7.50M | 75.62% |
| Dec 31, 2020 | 9.92M | -3.82M | -27.80% |
| Dec 31, 2019 | 13.73M | -29.19M | -68.00% |
| Dec 31, 2018 | 42.92M | 34.78M | 427.00% |
| Dec 31, 2017 | 8.14M | -2.17M | -21.02% |
| Dec 31, 2016 | 10.31M | 362.00K | 3.64% |
| Dec 31, 2015 | 9.95M | -1.15M | -10.36% |
| Dec 31, 2014 | 11.10M | -4.64M | -29.46% |
| Dec 31, 2013 | 15.74M | 2.67M | 20.47% |
| Dec 31, 2012 | 13.06M | -1.39M | -9.59% |
| Dec 31, 2011 | 14.45M | 334.00K | 2.37% |
| Dec 31, 2010 | 14.11M | 2.35M | 19.95% |
| Dec 31, 2009 | 11.77M | -5.31M | -31.09% |
| Dec 31, 2008 | 17.07M | -10.97M | -39.11% |
| Dec 31, 2007 | 28.04M | 22.49M | 405.59% |
| Dec 31, 2006 | 5.55M | 1.39M | 33.57% |
| Dec 31, 2005 | 4.15M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 156.33M |
| Cellectis | 65.14M |
| Innate Pharma | 9.01M |
| Sensorion | 5.81M |
| MaaT Pharma | 4.52M |
| DBV Technologies | 4.41M |
| ABIONYX Pharma | 4.06M |
| Adocia | 3.85M |
Transgene News
- 4 weeks ago - Transgene Transcript: Status update - Transcripts
- 4 weeks ago - Transgene Press release: Status update - Filings
- 4 weeks ago - Transgene Slides: Status update - Filings
- 5 weeks ago - Transgene Slides: Investor presentation - Filings
- 3 months ago - Transgene Earnings release: Q1 2026 - Filings
- 4 months ago - Transgene Earnings Call Transcript: H2 2025 - Transcripts
- 4 months ago - Transgene Annual report: H2 2025 - Filings
- 4 months ago - Transgene Earnings release: H2 2025 - Filings